Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01247974 · ClinicalTrials.gov registry record · NA
Evaluation Of New Onset Postoperative Atrial Fibrillation
A NA study, sponsored by Elutia.
- Completed
- Registry status
- NA
- Development phase
- 439
- Enrollment target
NCT01247974: Completed NA study, sponsored by Elutia.
NCT01247974 is a NA study that has completed, run by Elutia. The registered enrollment target is 439 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01247974, a NA study, has completed, sponsored by Elutia.
- COMPLETED
- Registry status
- NA
- Development phase
- 439 participants
- Enrollment target
Study Summary
This is a multi-center, prospective, randomized and controlled clinical trial comparing the safety and efficacy of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation by circumferentially reconstructing the normal pericardial anatomy following isolated, first-time, CABG procedures compared to subjects that do not undergo pericardial closure. This trial will be conducted at up to 20 clinical sites in the U.S.
Primary Outcome
A composite endpoint consisting of the following procedure- related serious adverse events occurring within 30 days postprocedure: * Death * Myocardial Infarction (MI) * Stroke * Mediastinal Reoperation * Percutaneous Coronary Intervention (PCI)
Interventions
- DEVICE CorMatrix ECM for Pericardial Closure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 439 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-12 |
| Phase | NA |
What the finished NCT01247974 record still lists
NCT01247974 is an interventional study that assigns participants to a tested intervention. The registered 439 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 1 intervention - of which CorMatrix ECM for Pericardial Closure is the first listed.
NCT01247974 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01247974 about?
NCT01247974 is a clinical study titled "Evaluation Of New Onset Postoperative Atrial Fibrillation". This is a multi-center, prospective, randomized and controlled clinical trial comparing the safety and efficacy of the CorMatrix ECM for Pericardial Closure to reduce the incidence of new onset postoperative atrial fibrillation by circumferentially reconstructing the normal pericardial anatomy follo...
What is the current status of trial NCT01247974?
This trial is currently completed. It is a NA study. The enrollment target is 439 participants. The study started on 2010-12. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01247974?
The interventions under investigation include: CorMatrix ECM for Pericardial Closure (DEVICE).
Who is sponsoring clinical trial NCT01247974?
This trial is sponsored by Elutia, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01247974's enrollment target sits among peer trials
439 235th of 2000 higher than 1,766 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05421663 · 439 participants · Phase 1
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
- NCT06235151 · 439 participants · Phase 3
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
- NCT05117619 · 440 participants · NA
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia